Determining the value of healthcare is a strenuous task that significantly depends on the decision environment and key players. Making decisions at the patient level should ideally be based on the medical expertise of the providers as well as the patient’s and caregiver’s personal preferences.
When making population-level healthcare decisions, a more complicated set of values should be taken into account by combining the viewpoints of many stakeholders, including patients, healthcare professionals, payers, and the general public, per multiple health economics and outcomes research studies.
The input of patients and the general public can help medical professionals treat a wider range of healthcare issues, such as addictions or mental health concerns. Dual Diagnosis Treatment Centers have emerged from this growing understanding of our complex healthcare environment, treating substance abuse disorders alongside depression and anxiety disorders.
It is essential to make dual diagnosis treatment centers and mental health treatment accessible to the wider population. Patient centricity means making “hard-to-reach” treatment available to the wider population, regardless of background. “Hard-to-reach” might mean different things to different individuals. People who belong to a group that generally does not engage in research owing to cultural or financial hurdles or physical or cognitive disabilities are deemed hard to reach for various studies.
Stakeholders are becoming more aware of the need for patient input in product development and approval processes, personalized therapies, and consumer involvement in healthcare decision-making. However, the science surrounding patient engagement and the components of a patient-centered guideline is still developing.
How Patient’s Voice Gets Interlinked With Patient-Centricity
Deloitte identifies three waves of patient-centricity:
- The majority of the companies we spoke with said that their commercial teams and strategies had made the most progress in assessing their patient-centricity initiatives.
- There is a common consensus that if companies want to promote patient-centric methods, they should begin much earlier and take patient-engagement strategies into account throughout the research and development (R&D) process.
- Adopting a corporate-wide approach Because the benefits of patient-centricity can be hard to measure, only a tiny portion of the companies we spoke with are focusing on measuring progress toward a more systematic practice or cultural transformation throughout the enterprise.
To become more patient-centric, life sciences companies need to first understand what that means. It is not simply about putting the patient first in everything that is done – but rather about creating a corporate culture and mindset that is focused on the patient. It requires a shift in thinking and is not always easy to do.
There are several ways that life sciences companies can become more patient-centric. One is to ensure the patient is always involved in the decision-making process. It includes including them in the development of new products and therapies, as well as in the clinical development services process. It is also essential to ensure that the patient’s voice gets heard and that they feel like they are a part of the team.
Another way to become more patient-centric is to focus on the patient’s experience. It means creating a patient-friendly environment and ensuring that the patient’s needs are always taken into account. It is also significant to provide education and support to the patient and to ensure they have access to the latest information and treatments.
Life sciences companies that want to become more patient-centric need to focus on the patient’s experience, and ensure they are always involved in the decision-making process. By doing so, they will be able to create a corporate culture focused on the patient, and that will ultimately benefit both the company and the patient.
Many organizations have focused on health economics and outcomes research studies to educate and empower patients to improve experiences, increase adherence’, and reduce costs, but many are still unsure how to connect efforts to business outcomes. Listening to and understanding patients is critical, but it can be difficult to incorporate the patient’s voice in brand strategy, product launch, patient services, and therapy development, continuously.
Life sciences companies need to focus on patient-centricity to be successful. It means putting the patient first and ensuring they are the focus of all decisions and initiatives. By doing this, companies can create a better patient experience and improve their bottom line. Patient-centricity has some benefits for healthcare providers and patients alike. For providers, it can lead to more efficient and effective care and increased patient satisfaction and loyalty. For patients, it can lead to better care coordination, more tailored treatment plans, and a better overall experience.